CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,777,896 | +12.1% | 1,827,047 | -8.5% | 0.42% | +14.6% |
| Q2 2023 | $44,418,943 | +6.9% | 1,996,357 | +4.0% | 0.36% | +1.4% |
| Q1 2023 | $41,569,417 | +10.9% | 1,919,179 | +3.9% | 0.36% | +8.8% |
| Q4 2022 | $37,497,967 | +7.7% | 1,846,281 | +35.9% | 0.33% | -4.3% |
| Q3 2022 | $34,827,000 | +11.7% | 1,358,319 | +3.6% | 0.34% | +16.9% |
| Q2 2022 | $31,177,000 | +6.6% | 1,311,038 | +0.9% | 0.30% | +21.9% |
| Q1 2022 | $29,249,000 | +43.3% | 1,298,812 | +26.0% | 0.24% | +47.6% |
| Q4 2021 | $20,414,000 | -2.3% | 1,031,007 | -2.9% | 0.16% | -11.4% |
| Q3 2021 | $20,897,000 | +26.6% | 1,061,845 | +41.5% | 0.18% | +25.9% |
| Q2 2021 | $16,507,000 | -10.0% | 750,351 | -2.6% | 0.15% | -17.4% |
| Q1 2021 | $18,332,000 | +71.0% | 770,565 | +88.0% | 0.18% | +56.1% |
| Q4 2020 | $10,722,000 | – | 409,844 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |